pyridinolcarbamate has been researched along with Cerebral Infarction in 1 studies
Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Le Poncin-Lafitte, M | 1 |
| Grosdemouge, C | 1 |
| Rapin, JR | 1 |
1 other study available for pyridinolcarbamate and Cerebral Infarction
| Article | Year |
|---|---|
[Drug protection of cerebral metabolism and behavioral activity after an acute ischemic stroke].
Topics: Acute Disease; Animals; Behavior, Animal; Brain Ischemia; Cerebral Infarction; Chloral Hydrate; Ener | 1982 |